Author

Junko Taketo

Observed name: Taketo Junko

Institution: Chugai Pharmaceutical Co., Ltd. (Japan)

Observed institution: Chugai Pharmaceutical Co., Ltd. (Japan)

OpenAlex ID: A5010923375

Advantages of evaluating γH2AX induction in non-clinical drug development

2018 · Shigeki Motoyama, Akira Takeiri, et al. · Genes and Environment · 23

Daily ascending dosing in cynomolgus monkeys to mitigate cytokine release syndrome induced by ERY22, surrogate for T-cell redirecting bispecific antibody ERY974 for cancer immunotherapy

2019 · Yoshika Iwata, Masanori Sasaki, et al. · Toxicology and Applied Pharmacology · 13

New DNA probes to detect aneugenicity in rat bone marrow micronucleated cells by a pan-centromeric FISH analysis

2013 · Akira Takeiri, Shigeki Motoyama, et al. · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · 9

Effects of two weeks of food restriction on toxicological parameters in cynomolgus monkeys

2023 · Nozomi Fujisawa, Tomochika Matsushita, et al. · EXPERIMENTAL ANIMALS · 2

Investigation and evaluation of gastrointestinal toxicity biomarkers in rats with different sites of gastrointestinal injury

2024 · Nozomi Fujisawa, Masaki Yamazaki, et al. · Food and Chemical Toxicology

癌免疫療法のためのt細胞再指向性二重特異性抗体ery974により誘導される,ery22によって誘発されたサイトカイン放出症候群を緩和するためのカニクイザルにおける毎日の上昇投与【jst・京大機械翻訳】

2019 · Iwata Yoshika, Sasaki Masanori, et al. · Toxicology and Applied Pharmacology

Works count: 6

Citation count: 47

H-index: 3

I10-index: 2